fura-2 has been researched along with rolipram in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Botana, LM; MacGlashan, DW | 1 |
Berto, L; Cortijo, J; Morcillo, EJ; Navarrete, C; Perpiñá, M; Sanz, C; Villagrasa, V | 1 |
Anderson, R; Feldman, C; Goolam Mahomed, A; Ramafi, G; Theron, AJ | 1 |
Botana, LM; de la Rosa, LA; Vieytes, MR; Vilariño, N | 1 |
Campos-Toimil, M; Keravis, T; Lugnier, C; Orallo, F; Takeda, K | 1 |
5 other study(ies) available for fura-2 and rolipram
Article | Year |
---|---|
Differential effects of cAMP-elevating drugs on stimulus-induced cytosolic calcium changes in human basophils.
Topics: 1-Methyl-3-isobutylxanthine; Anti-Inflammatory Agents, Non-Steroidal; Basophils; Calcium; Colforsin; Cyclic AMP; Cytosol; Fluorescent Dyes; Fura-2; Histamine Release; Humans; Immunoglobulin E; In Vitro Techniques; Kinetics; Leukotrienes; Microscopy, Fluorescence; N-Formylmethionine Leucyl-Phenylalanine; Pyrrolidinones; Rolipram; Time Factors | 1994 |
Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Calcium; Cardiotonic Agents; Cell Survival; Chemotaxis; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Fura-2; Humans; Imidazoles; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Parasympatholytics; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Rolipram; Thimerosal | 1996 |
Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
Topics: Adrenergic beta-Agonists; Adult; Albuterol; Bucladesine; Calcium; Calcium Radioisotopes; Cytosol; Fluorescent Dyes; Fura-2; Humans; In Vitro Techniques; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Phosphodiesterase Inhibitors; Pyrrolidinones; Rolipram; Superoxides; Theophylline | 1998 |
Modulation of thapsigargin-induced calcium mobilisation by cyclic AMP-elevating agents in human lymphocytes is insensitive to the action of the protein kinase A inhibitor H-89.
Topics: Adenosine Triphosphatases; Bucladesine; Calcium; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cytosol; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Humans; Isoquinolines; Lymphocytes; Microscopy, Fluorescence; Milrinone; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Rolipram; Sulfonamides; Thapsigargin; Time Factors | 2001 |
Short-term or long-term treatments with a phosphodiesterase-4 (PDE4) inhibitor result in opposing agonist-induced Ca(2+) responses in endothelial cells.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blotting, Northern; Blotting, Western; Bucladesine; Calcium; Calcium Signaling; Cell Line; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheximide; Data Interpretation, Statistical; Endothelial Cells; Fluorescent Dyes; Fura-2; Histamine; Humans; Phosphodiesterase 4 Inhibitors; Phosphodiesterase Inhibitors; Protein Synthesis Inhibitors; Rolipram | 2008 |